Abstract
A series of cinnamylpiperazine derivatives was synthesized using different benzophenone as starting material. The structures of the compounds were proved by their IR, 1H-NMR spectroscopic data and mass spectra data. The anticonvulsant activities of these compounds were evaluated with maximal electroshock (MES) test and rotarod test with intraperitoneal injection on KunMing mice. Among all the flunarizine analogues, no one exhibited better anticonvulsant activity than flunarizine. Flunarizine (4i) exhibited anticonvulsant activity with ED50 of 38.1 mg/kg, TD50 of 164.3 mg/kg and PI of 4.3 through administration intraperitoneal, and with ED50 of 56.8 mg/kg, TD50 of 456.3 mg/kg and PI of 8.0 through oral administration.
Keywords: Anticonvulsant, MES, Calcium channel, Flunarizine, Cinnarizine, Cinnamyl piperazine, Anticonvulsant activity, Cinnamylpiperazine Derivatives, Refractory childhood epilepsy, Structure activity relationship, Program (ADD), Drug Development, Intrinsic burst firing, Excitotoxic, Apoptotic cell, Pharmacology, Tonic maximal extension, Rotarod Test, Cinnarizine-induced parkinsonism
Letters in Drug Design & Discovery
Title: Synthesis and Anticonvulsant Activity of Some Cinnamylpiperazine Derivatives
Volume: 7 Issue: 9
Author(s): Chuan Hu, Zhi-Gang Sun, Cheng-Xi Wei and Zhe-Shan Quan
Affiliation:
Keywords: Anticonvulsant, MES, Calcium channel, Flunarizine, Cinnarizine, Cinnamyl piperazine, Anticonvulsant activity, Cinnamylpiperazine Derivatives, Refractory childhood epilepsy, Structure activity relationship, Program (ADD), Drug Development, Intrinsic burst firing, Excitotoxic, Apoptotic cell, Pharmacology, Tonic maximal extension, Rotarod Test, Cinnarizine-induced parkinsonism
Abstract: A series of cinnamylpiperazine derivatives was synthesized using different benzophenone as starting material. The structures of the compounds were proved by their IR, 1H-NMR spectroscopic data and mass spectra data. The anticonvulsant activities of these compounds were evaluated with maximal electroshock (MES) test and rotarod test with intraperitoneal injection on KunMing mice. Among all the flunarizine analogues, no one exhibited better anticonvulsant activity than flunarizine. Flunarizine (4i) exhibited anticonvulsant activity with ED50 of 38.1 mg/kg, TD50 of 164.3 mg/kg and PI of 4.3 through administration intraperitoneal, and with ED50 of 56.8 mg/kg, TD50 of 456.3 mg/kg and PI of 8.0 through oral administration.
Export Options
About this article
Cite this article as:
Hu Chuan, Sun Zhi-Gang, Wei Cheng-Xi and Quan Zhe-Shan, Synthesis and Anticonvulsant Activity of Some Cinnamylpiperazine Derivatives, Letters in Drug Design & Discovery 2010; 7 (9) . https://dx.doi.org/10.2174/157018010792929595
DOI https://dx.doi.org/10.2174/157018010792929595 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inflammatory Mediators in Epilepsy
Current Pharmaceutical Design Anticonvulsant and Antitubercular Activities of 6-Phenyl/Biphenyl-4-yl-2- [2-(pyridin-2-ylamino)-ethyl]- and 6-(Biphenyl-4yl)-2-(2N-subtituted amin- 1-yl)-ethyl derivatives of 4,5-dihydropyridazin-3(2H)-one
Letters in Drug Design & Discovery Reverse Iontophoretic Extraction of Gabapentin: A Mechanistic Study
Current Drug Delivery Post-Panning Computer-Aided Analysis of Phagotope Collections Selected with Neurocysticercosis Patient Polyclonal Antibodies Separation of Disease-Relevant and Irrelevant Peptide Sequences
Combinatorial Chemistry & High Throughput Screening Traumatic Brain Injury: Preclinical Imaging Diagnostic(s) and Therapeutic Approaches
Current Pharmaceutical Design Targeting Bacterial Metalloenzymes: A New Strategy for the Development of Anti-Infective Agents
Anti-Infective Agents in Medicinal Chemistry Sleep-Wake Patterns and Cognition of Older Adults with Amnestic Mild Cognitive Impairment (aMCI): A Comparison with Cognitively Healthy Adults and Moderate Alzheimer’s Disease Patients
Current Alzheimer Research Sodium Channel Blocking Activity and In-vivo Testing of New Phenylimidazole Derivatives
Letters in Drug Design & Discovery A Retrospective, Multi-Center Cohort Study Evaluating the Severity- Related Effects of Cerebrolysin Treatment on Clinical Outcomes in Traumatic Brain Injury
CNS & Neurological Disorders - Drug Targets Facts and Fiction: Cellular Models for High Throughput Screening for HIV-1 Reactivating Drugs
Current HIV Research Biological Signatures of Alzheimer’s Disease
Current Topics in Medicinal Chemistry Stem Cell Behavior at Hypothermia: A Review Article
Current Stem Cell Research & Therapy The Regulation of Brain Nucleoside Utilization
Current Metabolomics Molecular Docking Study, Green Synthesis and Pharmacological Evaluation of 1,3,4-thiadiazole Derivatives as Potential Antiepileptic Agents
Mini-Reviews in Medicinal Chemistry Towards a Unified Theory of Calmodulin Regulation (Calmodulation) of Voltage-Gated Calcium and Sodium Channels
Current Molecular Pharmacology Subdural Pharmacotherapy for the Treatment of Intractable Focal Neocortical Epilepsy
Drug Delivery Letters Tissue Distribution and Pharmacodynamics: A Complicated Relationship
Current Drug Metabolism Targeting PPAR Isoforms Following CNS Injury
Current Drug Targets Nanotechnology and Drug Delivery: Getting There is Only Half of the Challenge! (Commentary)
CNS & Neurological Disorders - Drug Targets Meet the Editorial Board
CNS & Neurological Disorders - Drug Targets